Literature DB >> 19029640

Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction.

Gregorio Caimi1, Maria Montana, Vincenzo Calandrino, Marco Caruso, Caterina Carollo, Anna Catania, Rosalia Lo Presti.   

Abstract

Nitric oxide (NO) has a role in the pathophysiology of acute and chronic cardiovascular events. We studied the plasma concentration of NO stable end products (nitrite and nitrate--NOx) in 43 patients aged<46 years, with recent acute myocardial infarction (AMI). The evaluation was effected at the initial stage, after 3 and 12 months. We subdivided the patients into subgroups according to the number of the main cardiovascular risk factors and to the extent of coronary disease. In the whole group the NOx concentration was initially increased and progressively decreased after 3 and 12 months, remaining at both times significantly higher than in control subjects. The patients with more risk factors had a significantly higher NOx concentration. In conclusion, the persisting high NOx concentration in AMI patients is the expression of a prolonged inflammatory condition and is significantly influenced by the simultaneous presence of several cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029640

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  2 in total

1.  Increased inducible nitric oxide synthase (iNOS) expression in human myocardial infarction.

Authors:  Verena Wilmes; Stefanie Scheiper; Winta Roehr; Constanze Niess; Stefan Kippenberger; Katja Steinhorst; Marcel A Verhoff; Silke Kauferstein
Journal:  Int J Legal Med       Date:  2019-03-29       Impact factor: 2.686

2.  Plasma Nitrate and Incidence of Cardiovascular Disease and All-Cause Mortality in the Community: The Framingham Offspring Study.

Authors:  Renke Maas; Vanessa Xanthakis; Thomas Göen; Johannes Müller; Edzard Schwedhelm; Rainer H Böger; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2017-11-18       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.